Level C· Early human research exploring benefitsProspective StudyPubMed

PVDF piezoelectric neural conduit incorporated pre-differentiated adipose-derived stem cells may accelerate the repair of peripheral nerve injury.

Li M., Zhang P., Zhang D.

Prospective Study on Hip, published in Med Hypotheses (2018) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Med Hypotheses (2018)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
29602466
DOI
10.1016/j.mehy.2018.02.027
Citations
14

Abstract (original English)

Peripheral nerve injury is a common trauma disease which often results in sensory and motor dysfunction. However, the surgical repair for peripheral nerve injury, especially for large segmental defects, is not satisfactory. Growing evidences suggest that artificial neural conduit combined with stem cells is potential tissue engineering remediation method for peripheral nerve injury. But, selections of biomaterials and stem cells are still being debated. Based on the findings from previous studies, we hypothesize that PVDF piezoelectric neural conduit incorporated Schwann-like cells which pre-differentiated from adipose-derived stem cells may substantially promote the repair of peripheral nerve injury. This novel technique may help clinical surgeons cure the seriously injured patients better and point out a new direction for neural tissue engineering researchers select the suitable biomaterials and seed cells.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AdipocytesAdipose TissueAnimalsBiocompatible MaterialsCell DifferentiationElectric Stimulation TherapyHumansLab-On-A-Chip DevicesNerve RegenerationPC12 Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research